Table of Contents
Scholarly Research Exchange
Volume 2009, Article ID 641360, 4 pages
http://dx.doi.org/10.3814/2009/641360
Clinical Study

IgA Anticardiolipin in Patients with Gastroenteric Tumor

1Physiopathology Section, Department of Clinical and Experimental Medicine, Policlinico Monteluce, Via Brunamonti, 06100 Perugia, Italy
2Chemo-Clinical Analysis Laboratory, Silvestrini Hospital, 06100 Perugia, Italy

Received 22 July 2008; Revised 18 November 2008; Accepted 8 January 2009

Copyright © 2009 Ilaria Bernardini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ph. Makar, J. S. Vanderheyden, and A. Verheyen, “Maternal and fetal complications associating lupus anticoagulant and its management; three case reports,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 36, no. 1-2, pp. 185–195, 1990. View at Publisher · View at Google Scholar
  2. M. Galli, G. Finazzi, and T. Barbui, “Antiphospholipid antibodies: predictive value of laboratory tests,” Thrombosis and Haemostasis, vol. 78, no. 1, pp. 75–78, 1997. View at Google Scholar
  3. M. Petri, “Pathogenesis and treatment of the antiphospholipid antibody syndrome,” Medical Clinics of North America, vol. 81, no. 1, pp. 151–177, 1997. View at Publisher · View at Google Scholar
  4. J.-C. Piette, “Towards improved criteria for the antiphospholipid syndrome,” Lupus, vol. 7, pp. S149–S157, 1998. View at Google Scholar
  5. M. Samarkos, K. A. Davies, C. Gordon, and S. Loizou, “Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome,” Clinical Rheumatology, vol. 25, no. 2, pp. 199–204, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. A. Selva-O'Callaghan, J. Ordi-Ros, F. Monegal-Ferran, N. Martinez, F. Cortes-Hernandez, and M. Vilardell-Tarres, “IgA anticardiolipin antibodies—relation with other antiphospholipid antibodies and clinical significance,” Thrombosis and Haemostasis, vol. 79, no. 2, pp. 282–285, 1998. View at Google Scholar
  7. S. Carmo-Pereira, M. L. Bertolaccini, A. Escudero-Contreras, M. A. Khamashta, and G. R. V. Hughes, “Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity,” Annals of the Rheumatic Diseases, vol. 62, no. 6, pp. 540–543, 2003. View at Publisher · View at Google Scholar
  8. Y.-H. Yang, M.-T. Huang, S.-C. Lin, Y.-T. Lin, M.-J. Tsai, and B.-L. Chiang, “Increased transforming growth factor-beta (TGF-β)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura,” Clinical & Experimental Immunology, vol. 122, no. 2, pp. 285–290, 2000. View at Publisher · View at Google Scholar
  9. A. D. Burden, I. W. Gibson, R. S. C. Rodger, and D. M. Tillman, “IgA anticardiolipin antibodies associated with Henoch-Schönlein purpura,” Journal of the American Academy of Dermatology, vol. 31, no. 5, part 2, pp. 857–860, 1994. View at Publisher · View at Google Scholar
  10. E. Cucurull, A. E. Gharavi, E. Diri, E. Mendez, D. Kapoor, and L. R. Espinoza, “IgA anticardiolipin and anti-β2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus,” American Journal of the Medical Sciences, vol. 318, no. 1, pp. 55–60, 1999. View at Publisher · View at Google Scholar
  11. M. Gupta, R. Johann-Liang, J. B. Bussel, W. M. Gersony, and T. J. Lehman, “Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease,” Cardiology, vol. 97, no. 4, pp. 180–182, 2002. View at Publisher · View at Google Scholar
  12. G. M. Iverson, C. A. von Mühlen, H. L. Staub, A. J. Lassen, W. Binder, and G. L. Norman, “Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI,” Journal of Autoimmunity, vol. 27, no. 4, pp. 266–271, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. W. A. Wilson, Z. Faghiri, F. Taheri, and A. E. Gharavi, “Significance of IgA antiphospholipid antibodies,” Lupus, vol. 7, pp. S110–S113, 1998. View at Google Scholar
  14. C. Tajima, Y. Suzuki, Y. Mizushima, and Y. Ichikawa, “Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis,” Journal of Rheumatology, vol. 25, no. 9, pp. 1730–1736, 1998. View at Google Scholar
  15. A. D. Burden, D. M. Tillman, P. Foley, and E. Holme, “IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis,” Journal of the American Academy of Dermatology, vol. 35, no. 3, part 1, pp. 411–415, 1996. View at Publisher · View at Google Scholar
  16. O. Vaarala, T. Palosuo, M. Kleemola, and K. Aho, “Anticardiolipin response in acute infections,” Clinical Immunology and Immunopathology, vol. 41, no. 1, pp. 8–15, 1986. View at Publisher · View at Google Scholar
  17. A. J. Macpherson and K. McCoy, “APRIL in the intestine: a good destination for immunoglobulin A2,” Immunity, vol. 26, no. 6, pp. 755–757, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. A. J. Macpherson and E. Slack, “The functional interactions of commensal bacteria with intestinal secretory IgA,” Current Opinion in Gastroenterology, vol. 23, no. 6, pp. 673–678, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. K. H. Yoon, A. Wong, T. Shakespeare, and P. Sivalingam, “High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis,” Lupus, vol. 12, no. 2, pp. 112–116, 2003. View at Publisher · View at Google Scholar
  20. L. Pugliese, I. Bernardini, E. Pacifico, M. Viola-Magni, and E. Albi, “Antiphospholipid antibodies in patients with cancer,” International Journal of Immunopathology and Pharmacology, vol. 19, no. 4, pp. 871–888, 2006. View at Google Scholar
  21. A. J. Macpherson and E. Slack, “The functional interactions of commensal bacteria with intestinal secretory IgA,” Current Opinion in Gastroenterology, vol. 23, no. 6, pp. 673–678, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. P. Michetti, M. J. Mahan, J. M. Slauch, J. J. Mekalanos, and M. R. Neutra, “Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium,” Infection and Immunity, vol. 60, no. 5, pp. 1786–1792, 1992. View at Google Scholar
  23. A. Mellander, A. Mattsson, A.-M. Svennerholm, and H. Sjovall, “Relationship between interdigestive motility and secretion of immunoglobulin A in human proximal small intestine,” Digestive Diseases and Sciences, vol. 42, no. 3, pp. 554–567, 1997. View at Publisher · View at Google Scholar
  24. S. Kato, K. Ozawa, N. Ando, H. Naganuma, K. Iinuma, and H. Nagura, “Immunoglobulin A enteropathy: a possible variant of Henoch-Schönlein purpura,” Digestive Diseases and Sciences, vol. 49, no. 11-12, pp. 1777–1781, 2004. View at Publisher · View at Google Scholar
  25. S. S. Pierangeli, X. W. Liu, J. H. Barker, G. Anderson, and E. N. Harris, “Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome,” Thrombosis and Haemostasis, vol. 74, no. 5, pp. 1361–1367, 1995. View at Google Scholar
  26. H. L. Staub, M. Franck, A. Ranzolin, G. L. Norman, G. M. Iverson, and C. A. von Mühlen, “IgA antibodies to beta2-glycoprotein I and atherosclerosis,” Autoimmunity Reviews, vol. 6, no. 2, pp. 104–106, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. S. Pusterla, S. Previtali, S. Marziali et al., “Antiphospholipid antibodies in lymphoma: prevalence and clinical significance,” The Hematology Journal, vol. 5, no. 4, pp. 341–346, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. A. Orsino, R. Schneider, G. DeVeber et al., “Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome,” Journal of Pediatric Hematology/Oncology, vol. 26, no. 5, pp. 327–330, 2004. View at Publisher · View at Google Scholar
  29. W. Miesbach, R. A. Asherson, R. Cervera et al., “The catastrophic antiphospholipid (Asherson's) syndrome and malignancies,” Autoimmunity Reviews, vol. 6, no. 2, pp. 94–97, 2006. View at Publisher · View at Google Scholar · View at PubMed